January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …
OFF
January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...
1 week from now
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …
ratiotx.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
1 week from now
Jan 17, 2024 · "This funding advances Ratio's technology platforms and will help launch clinical trials for our FAP-targeted radiotherapeutic which aims to treat a broad array of solid-tumor …
prnewswire.com
OFF
Ratio Raises Series B To Advance Radiotherapeutic Into Clinic
1 week from now
Jan 19, 2024 · Ratio Therapeutics Inc. has closed a $50 million series B financing to expand application of its proprietary technology platforms, Trillium and Macropa, to develop novel best …
bioworld.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
1 week from now
BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …
biospace.com
OFF
Ratio Therapeutics Secures $50M Series B To Develop Cancer …
1 week from now
Jan 18, 2024 · The company aims to move its therapeutic for solid-tumor cancers into clinical trials this year. ... Boston-based pharmaceutical company Ratio Therapeutics has announced …
builtinboston.com
OFF
Ratio Therapeutics Raises $50M For Tumor-targeting …
1 week from now
Jan 17, 2024 · The company also announced plans to move into its new, 19,000-square-foot facility in Boston's Seaport District, which it officially opened in May 2023. Hoppin said the …
bizjournals.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
1 week from now
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90 Million Since 2021 Launch. BOSTON, MA, USA I January 17, 2024 I Ratio …
pipelinereview.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
1 week from now
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment PR Newswire BOSTON, Jan. 17, 2024 Boston-Based...
marketwatch.com
OFF
Ratio Therapeutics Raises $50M In Series B Financing
1 week from now
Jan 17, 2024 · In July 2023, Ratio began studying its FAP-targeted, Cu-64-labeled radiopharmaceutical, RTX-1363S, in a Phase I trial in healthy volunteers. According to a …
precisionmedicineonline.com
OFF
Ratio Therapeutics Secures Funds For Cancer Radiotherapies
1 week from now
Jan 18, 2024 · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …
pharmaceutical-technology.com
OFF
Media - Ratio Therapeutics
1 week from now
Boston’s Ratio Therapeutics Raises $50M Series B For R&D. Law360 | January 17th, 2024. Pharmaceutical startup Ratio Therapeutics has raised a fresh round of funding, the company …
ratiotx.com
OFF
January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...
1 week from now
On January 17, 2024 Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the …
1stoncology.com
OFF
Ratio Announces Expansion Of Manufacturing Agreement With …
1 week from now
Mar 12, 2024 · The company also recently announced a $50M Series B financing which will significantly drive the clinical advancement of Ratio's first FAP-targeted therapeutic candidate …
prnewswire.com
OFF
Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase
1 week from now
Jan 17, 2024 · Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... Law360 — Boston's …
crunchbase.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
1 week from now
BOSTON, January 17, 2024-- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for …
vcaonline.com
OFF
Ratio Therapeutics Closes $50M Series B Financing - Citybiz
1 week from now
Jan 17, 2024 · Ratio Therapeutics Inc., a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and …
citybiz.co
OFF
CDMO PharmaLogic Expands Deal With Radiopharma Specialist Ratio
1 week from now
Mar 18, 2024 · Coming off a $50 million series B financing round, radiopharmaceutical developer Ratio Therapeutics has expanded its partnership with Florida-based CDMO PharmaLogic.. …
fiercepharma.com
FAQs about January 17th, 2024: Ratio Therapeutics Announces $50M Series B ... Coupon?
Will ratio Therapeutics move its first drug candidate into clinical trials?
What is the proposed outcome of radiation therapy to the heart?
Who backed ratio's $50M Series B financing?
Why are radiation treatments most effective for lymphoma?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
